O. Public Health (Issues pertaining to preparedness for and response to outbreaks including those linked to agents of bioterror, foodborne, waterborne, vector borne, zoonotic diseases, vaccine-preventable diseases and social determinants of health)
Poster Session: Public Health
Ahuva Averin, MPP
Avalere Health
Boston, Massachusetts, United States
Mark Rozenbaum, PhD, M.B.A.
Global Value & Evidence Team Lead Pneumococcal Vaccines
Pfizer Inc.
Randstad, Noord-Holland, Netherlands
Derek Weycker, Ph.D.
Avalere Health
Washington, District of Columbia, United States
Rotem Lapidot, MD, MSCI
Specialist
Boston Medical Center
Brookline, Massachusetts, United States
Amanda C. Miles, MPH (she/her/hers)
Senior Manager, RWE Scientist, Vaccines
Pfizer
New York, NY, United States
Maria J. Tort, PhD
Pfizer, Inc
Collegeville, Pennsylvania, United States
Jeffrey T. Vietri, PhD
Director, HTA, Value, & Evidence
Pfizer, Inc.
Collegeville, PA, United States
Alexander Lonshteyn, PhD
Avalere Health
Boston, Massachusetts, United States
Stephen I. Pelton, MD
Pediatric I D physician
Boston Medical Center
Boston, Massachusetts, United States